Dolby Laboratories Inc. A Stock
A loss of -1.770% shows a downward development for Dolby Laboratories Inc. A.
Dolby Laboratories Inc. A is currently one of the favorites of our community with 10 Buy predictions and no Sell predictions.
With a target price of 82 € there is a positive potential of 47.75% for Dolby Laboratories Inc. A compared to the current price of 55.5 €.
Pros and Cons of Dolby Laboratories Inc. A in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dolby Laboratories Inc. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dolby Laboratories Inc. A | -1.770% | -0.893% | -1.770% | -25.503% | -0.893% | -26.471% | -33.133% |
| Roku | -0.240% | -2.520% | 18.015% | 26.629% | -12.572% | 46.143% | -72.603% |
| Alibaba Pictures Group Ltd | -2.040% | 0.690% | -24.742% | 19.672% | -21.081% | 49.590% | -30.476% |
| Imax China Holding Inc | -2.420% | -3.468% | -2.907% | -13.918% | -5.114% | -16.080% | -54.121% |
Comments
Dolby Laboratories (NYSE:DLB) had its "buy" rating reaffirmed by analysts at Rosenblatt Securities. They now have a $85.00 price target on the stock.
Show more
Ratings data for DLB provided by MarketBeat
Dolby Laboratories (NYSE:DLB) had its price target lowered by analysts at Barrington Research from $95.00 to $90.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for DLB provided by MarketBeat
Dolby Laboratories (NYSE:DLB) had its "buy" rating reaffirmed by analysts at Rosenblatt Securities. They now have a $85.00 price target on the stock.
Show more
Ratings data for DLB provided by MarketBeat
News
Dolby Stock Down 18%, Yet This $8 Million Bet Signals Turnaround Potential
On February 13, 2026, Neo Ivy Capital Management disclosed a new position in Dolby Laboratories (NYSE:DLB), acquiring 117,964 shares in a trade estimated at $7.58 million.
Neo Ivy Capital Management
Is Dolby Stock a Buy or Sell After the CEO Sold Shares Worth $2.5 Million?
President and CEO Kevin J. Yeaman executed an option exercise and immediate sale of 36,699 shares of Dolby Laboratories (NYSE:DLB) on November 24, 2025; see SEC Form 4 filing.
Transaction value
Dolby Laboratories: A Strong Player in Audio Technology with Promising Potential
Explore the exciting world of Dolby Laboratories (NYSE: DLB) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into